Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica
about
Biocompatibility assessment of Si-based nano- and micro-particlesUnderstanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdlesMolecular organization of hydrophobic molecules and co-adsorbed water in SBA-15 ordered mesoporous silica material.Packaging biological cargoes in mesoporous materials: opportunities for drug deliveryIncreasing the oral bioavailability of poorly water-soluble carbamazepine using immediate-release pellets supported on SBA-15 mesoporous silicaTargeted modulation of cell differentiation in distinct regions of the gastrointestinal tract via oral administration of differently PEG-PEI functionalized mesoporous silica nanoparticles.Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles.Evaluation of Three Amorphous Drug Delivery Technologies to Improve the Oral Absorption of Flubendazole.Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica.Drug delivery from ordered mesoporous matrices.Ordered mesoporous silicates as matrices for controlled release of drugs.Current developments in the therapy of protozoan infections.Synthesis, toxicology and potential of ordered mesoporous materials in nanomedicine.Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.Physical stabilization of low-molecular-weight amorphous drugs in the solid state: a material science approach.Silica-based mesoporous nanobiomaterials as promoter of bone regeneration process.Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2)Mesoporous silica formulation strategies for drug dissolution enhancement: a review.Mesoporous silica-based dosage forms improve bioavailability of poorly soluble drugs in pigs: case example fenofibrate.Self-Assembly of Pluronic F127-Silica Spherical Core-Shell Nanoparticles in Cubic Close-Packed Structures.High drug load, stable, manufacturable and bioavailable fenofibrate formulations in mesoporous silica: a comparison of spray drying versus solvent impregnation methods.Silica-lipid hybrid (SLH) versus non-lipid formulations for optimising the dose-dependent oral absorption of celecoxib.Mesoporous calcium carbonate as a phase stabilizer of amorphous celecoxib--an approach to increase the bioavailability of poorly soluble pharmaceutical substances.Designing ordered mesoporous aluminosilicates under acidic conditions via an intrinsic hydrolysis method.Mechanistic investigation of mixing and segregation of ordered mixtures: experiments and numerical simulations.Drug specific, tuning of an ionic liquid's hydrophilic–lipophilic balance to improve water solubility of poorly soluble active pharmaceutical ingredientsComparison of different silica microporous structures as drug delivery systems for in vitro models of solid tumorsNanostructured Mesoporous Silicas for Bone Tissue Regeneration
P2860
Q28389467-C66E9D8D-26B3-479F-B874-0F3B5F72B579Q33683206-3E0C65B3-ADC3-4FE7-A290-3CC3D3D5254EQ33770353-F14EC05A-7D21-4751-B4FF-64D30B87E6FCQ34576316-8EC54777-5EE1-47EA-BFE4-3BB406A7DEC5Q36433678-BF7F30AD-F363-473F-9CF0-4BD0EBAF54B9Q36498783-267C7D86-19B5-4DAE-802A-9BB4AF8F1598Q36975416-E8458C3E-7D1B-435F-938D-505E3B9328D8Q37183352-754F3583-3A23-44A3-AA34-6F375CA5ED4BQ37254914-1A037CB5-951D-4B49-8C59-32CC2F086903Q37639315-FC1C03DF-DAE8-47A1-87FB-79E8358A4962Q37822183-E7949D85-8E39-4C87-B764-AA07DCE7E6A5Q37883063-75578F36-2069-44DC-A997-66BD176EF129Q37906636-55001AB2-CA13-49DA-B92D-A3EDED86FE1EQ37989408-C8F050EB-15C7-4018-8024-2E34C7C18536Q38257177-F6825C7A-4AA3-4214-84F5-CB14A8283E80Q38502952-CE5F362D-C53D-4D81-A868-ED80F8D012A3Q38619498-B73682D1-447F-42BA-B459-2754E7B39232Q38628433-852836A8-2A3B-471C-8B1E-6F5C5CE2ECFBQ38669102-43B6E868-A640-45F0-90EE-6F7E8C0A85CBQ41813702-69EAA827-C5E0-4992-B585-CEDBCB2AC1D9Q42661929-0B205255-DC96-4810-87FF-494098033407Q45164124-ED3A173B-912E-4DC4-A644-24054E43BF6BQ46391492-CC23F876-E12C-4479-AC60-34D10D17A96BQ46443087-444A8555-33DD-40B0-9AD8-8D671E06AB48Q50855269-349B9BF9-90B0-4F44-997B-854319DAC84EQ57087020-D15C009F-5605-44E5-AD50-270225E2CEBBQ57650982-40A8F4EC-5D26-407B-B1F7-8B91051AA900Q58645575-1FB78757-BDA7-4E28-BC73-31653C0B6D9B
P2860
Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Increasing the oral bioavailab ...... with ordered mesoporous silica
@ast
Increasing the oral bioavailab ...... with ordered mesoporous silica
@en
Increasing the oral bioavailab ...... with ordered mesoporous silica
@nl
type
label
Increasing the oral bioavailab ...... with ordered mesoporous silica
@ast
Increasing the oral bioavailab ...... with ordered mesoporous silica
@en
Increasing the oral bioavailab ...... with ordered mesoporous silica
@nl
prefLabel
Increasing the oral bioavailab ...... with ordered mesoporous silica
@ast
Increasing the oral bioavailab ...... with ordered mesoporous silica
@en
Increasing the oral bioavailab ...... with ordered mesoporous silica
@nl
P2093
P50
P3181
P1476
Increasing the oral bioavailab ...... with ordered mesoporous silica
@en
P2093
Caroline A Aerts
Guy Van den Mooter
Jan Van Humbeeck
Jasper A G Jammaer
Randy Mellaerts
P304
P3181
P356
10.1016/J.EJPB.2007.11.006
P407
P577
2008-05-01T00:00:00Z